CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to VERA

Phase 3

Development Phase

1

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
3w
VERAPDUFA
Phase 3Positive

FDA PDUFA Date VTR-297 (standard)

Atacicept
Oct 6
SEC
Development History
Sep '26
VERAPhase 2
Positive

Atacicept Phase 2 Est. Readout

Atacicept
Sep 2026~
CT.gov
Competitive Landscape

1 competitor in IgA Nephropathy (IgAN)

View Full Landscape
Drug Information

Target Indication

IgA Nephropathy (IgAN)

Clinical Trial

NCT07020923

Last updated: 12/29/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.